What does Deciphera Pharmaceuticals, Inc. do?

Jun 22 2025 06:58 PM IST
share
Share Via
Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments. As of March 2024, it reported net sales of $45 million and a net loss of $45 million, with a market cap of approximately $2.21 billion.
Overview:
Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company in the biotechnology industry, focused on developing drugs to improve the lives of cancer patients.

Financial Snapshot:
Most recent Net Sales: 45 Million (Quarterly Results - Mar 2024)
Most recent Net Profit: -45 Million (Quarterly Results - Mar 2024)
Market-cap: USD 2,212.92 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 9,118.37%
Debt Equity: -0.85
Return on Equity: -60.25%
Price to Book: 7.00

Contact Details:
Address: 200 Smith St, WALTHAM MA: 02451-0099
Tel: ['1 781 2096400', '1 212 6001902']
Fax: 1 302 6555049
Website: https://www.deciphera.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News